Haemophilus b conjugate vaccine (Yuanda Weixin Life Science)

b型流感嗜血杆菌结合疫苗（远大赛威信生命科学）

Report date: 2024/07/11 17:29:19

Base Information

Drug NameHaemophilus b conjugate vaccine (Yuanda Weixin Life Science)
Drug Alias NameN/A
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Biological material > Toxoid vaccineVaccines > Biological material > Bacterial vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHaemophilus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYuanda Weixin Life Science (Nanjing) Co LtdFar contest Weixin Life Science (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFar contest Weixin Life Science (Hangzhou) Co LtdYuanda Weixin Life Science (Nanjing) Co Ltd
Inactive CompaniesN/A
Active IndicationsHaemophilus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A